First Washington Corp’s AbbVie ABBV Stock Holding History

First Washington Corp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-600	Closed	-$37K	–	69
2016 Q2	$37K	Hold	600	–	–	0.02%	69
2016 Q1	$34K	Hold	600	–	–	0.02%	69
2015 Q4	$36K	Hold	600	–	–	0.02%	73
2015 Q3	$33K	Hold	600	–	–	0.02%	82
2015 Q2	$40K	Hold	600	–	–	0.02%	77
2015 Q1	$35K	Hold	600	–	–	0.02%	77
2014 Q4	$39K	Hold	600	–	–	0.02%	73
2014 Q3	$35K	Hold	600	–	–	0.02%	80
2014 Q2	$34K	Hold	600	–	–	0.02%	96
2014 Q1	$31K	Hold	600	–	–	0.02%	98
2013 Q4	$32K	Buy	+600	New	+$29.5K	0.02%	99

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

First Washington Corp's ABBV Position: Q3 2016 in Review

First Washington Corp sold out of AbbVie (ABBV) in Q3 2016, closing a stake of 600 shares — an estimated $37K sold.

First Washington Corp first reported a position in ABBV in Q4 2013 and held it in 11 quarters. The position peaked at $40K in Q2 2015. 1,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

First Washington Corp reported no remaining AbbVie position as of Q3 2016 after selling out during the quarter.
First Washington Corp sold 600 AbbVie shares in Q3 2016, an estimated $37K.
First Washington Corp first reported a position in AbbVie in Q4 2013 and held it in 11 quarters.
First Washington Corp's AbbVie position peaked at $40K in Q2 2015.
1,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on First Washington Corp's 13F filing for Q3 2016, filed 3 Nov 2016.